Introduction
The Rho GTPases are members of the Ras superfamily of monomeric low molecular mass (approx. 21 kDa) guanine nucleotide-binding proteins. By cycling between an active (GTP-bound) and an inactive (GDP-bound) state, Rho GTPases function as molecular switches to control signal transduction pathways in regulation of a plethora of cellular processes, including cytoskeleton reorganization, gene transcription, cell-cycle progression, and survival (Bishop and Hall, 2000) . The diverse function of Rho GTPases is mediated through interacting with, and modulating the activity of, respective effector proteins. Rho, Rac, and Cdc42 are the three best-characterized members of the family for their roles in the reorganization of the actin cytoskeleton (Paterson et al., 1990; Nobes and Hall, 1995) . Rho induces the formation of focal adhesions and stress fibers, this effect being mediated through the cooperation of two downstream effector proteins, the Rho-associated kinase (ROCK/ROK/Rho kinase) and the mammalian orthologue of the Drosophila Diaphanous protein, mDia (Ishizaki et al., 1997; Watanabe et al., 1999; Sahai and Marshall, 2002) . Cdc42 and Rac, respectively, induce the formation of filopodia and lamellipodia Kozma et al., 1995) , and the effectors of these two GTPases, WiskottAldrich-syndrome protein (WASP)/N-WASP (the N isoform of WASP) and WASP-like Verprolin-homologous protein (WAVE, also known as Scar), mediate actin nucleation by binding to the Arp2/3 complex (Machesky and Insall, 1998; Rohatgi et al., 1999) . More than 30 potential effector proteins have been identified for Rho, Rac, and CDC42, including protein kinases, lipid kinases, phosphatase, lipases, and a number of scaffold proteins (Bishop and Hall, 2000) . Much effort has now been made in characterizing the biological abilities of Rho GTPases in addition to actin organization and in identifying the individual effectors that transit the distinct signal pathways linked to these cellular responses.
Dysfunctional regulation of Rho GTPase family protein activation has been implicated in certain aspects of cancer development. Activated Rho protein mutants can transform fibroblasts (Qiu et al., 1995) . Rho protein can promote cell cycle progression by affecting CDK activity through regulation of the levels of cyclin D1, p21
WAF1
, and p27
KIP1 (Weber et al., 1997; Olson et al., 1998) . Transcriptional upregulation of the levels of particular Rho proteins has been described in many types of human cancers, including cancers of the colon, breast, lung, and pancreas (Suwa et al., 1998; Fritz et al., 1999; Schnelzer et al., 2000; van Golen et al., 2000; Kleer et al., 2002) . In the case of breast cancer, increased RhoA expression correlated with malignancy (Fritz et al., 2002) , and RhoC expression was highly associated with invasive tumors (Kleer et al., 2002) . RhoC expression also correlated significantly with tumor progression in ductal adenocarcinoma of the pancreas (Suwa et al., 1998) . In line with the role of Rho proteins in tumor invasion and metastasis, reduced expression of RhoGDI2 has recently been shown to correlate with increasing stage and grade of tumors from several common sites (Gildea et al., 2002) . Other evidences also suggest that overactivated Rho-mediated cellular functions contribute to cancer. Members of the diffuse B cell lymphoma-derived (Dbl) family of Rho GEFs have transforming activity. Naturally occurring mutations resulting in constitutive activation of Rho GEFs have been described in Dbl, LARG, and Tiam (Srivastava et al., 1986; Engers et al., 2000; Kourlas et al., 2000) . Overexpression or activation of Rho GTPase downstream effector proteins ROCK and protein kinase C-related kinase (PRK1) have recently been described in several human cancers (Kaneko et al., 2002; Ikeda et al., 2003; Kamai et al., 2003; Metzger et al., 2003; Zhou et al., 2003) . We have previously shown that RTKN, a Rho effector protein, is overexpressed in human gastric cancer (GC) (Liu et al., 2004) . RTKN was initially isolated as a scaffold protein interacting with GTPbound form of Rho (Reid et al., 1996) . Other than interacting with TIP-1 (human T cell lymphotrophic virus, type 1 Tax interacting protein-1) to facilitate Rhomediated activation of serum response element (Reynaud et al., 2000) , the role of RTKN involved in Rho-mediated signal transduction remains largely unknown. In this study, we demonstrated that RTKN activation links the Rho signal to nuclear factor-kB (NFkB) activation, leading to increased cell survival by transactivating antiapoptotic genes downstream of NFkB, supporting an important role of Rho/RTKN/NF-kB signaling pathway in gastric tumorigenesis. In line with the prosurvival effect of Rho/RTKN/NF-kB signaling pathway, we also showed that overexpression of RTKN leads to increased chemoresistance in gastric AGS cells and blockade of NF-kB activity greatly attenuates the resistance to chemotherapeutic drug, suggesting that novel therapeutic regimens including NF-kB blockers may represent a promising approach for treating a subset of GCs with increased chemoresistance.
Results

Overexpression of RTKN inhibits apoptosis induced by various stimuli
We have previously shown that RTKN was expressed at an elevated level in human GC, and overexpression of RTKN was associated with an increased survival (Liu et al., 2004) . To test whether RTKN-mediated signaling pathway may confer cell resistance to apoptotic insults and enables cells to evade apoptosis during the process of transformation, we first examined the expression of RTKN in a serious of normal and transformed cells. As shown in Figure 1 , RTKN expression was low in all the test normal cells, including several human fibroblasts and embryonic intestine-derived 407 cells, but its expression was readily detected in many of the cancerderived cell lines. To explore the role of RTKN in cell survival, AGS gastric cells that express endogenous RTKN at a low level were transfected with RTKN expression vector. Cell clones stably expressing RTKN were established as AGS/RTKN cells, and compared with AGS/Control cells, the same cells transfected with a control vector, for their ability to withstand apoptosis induced by various stimuli. AGS, like many other cancer cell lines, shows a time-dependent increase in the number of apoptotic cells upon serum deprivation (Kanai et al., 2001; Tovar Sepulveda et al., 2002) . As shown, marked apoptosis was observed in the AGS/ Control cells when cultured in serum-free medium, with the sub-G 1 apoptotic population increasing to 32% in 48 h (Figure 2a ). In contrast, AGS/RTKN cells were significantly more resistant to serum deprivationinduced apoptosis, with about 4-5% of the cells showing apoptosis after 48 h in serum-free medium. RTKN-mediated survival was not unique to AGS cells, as similar results were also obtained with non-small-cell lung cancer H1299 cells. Figure 2b shows that two H1299/RTKN clones were established and they also displayed increased resistance to serum deprivationinduced apoptosis, and the increase was correlated to the level of RTKN. Our data therefore showed that RTKN overexpression protects cells from serum depletion-induced apoptosis. To test whether RTKN protected cells from other apoptotic insults, AGC/Control and AGS/RTKN cells were subjected to sodium butyrate (NaBT) treatments, which are known to induce apoptosis in many cell types, including AGS cells. Our data showed that overexpression of RTKN also rescued AGS cells from NaBT-induced apoptosis (Liu et al., 2004) .
Elimination of RTKN expression sensitizes cells to apoptotic insult
To further confirm the antiapoptotic role of RTKN, synthetic siRNA was used to knockdown the expression of RTKN in AGS cells. Two sets of small interfering RNA (siRNA) were employed: siRNA R , which was designed to target at RTKN to specifically inhibit RTKN expression, and siRNA C , the control siRNA that have no known homology with mammalian genes and should have no effect on RTKN expression. The introduction of siRNA R effectively abolished RTKN expression in the AGS/RTKN cells (Figure 3a) , and the elimination of RTKN expression was accompanied with the loss of resistance to apoptosis (Figure 3b , panel 4). In fact, introduction of siRNA R into AGS/RTKN cells not only resulted in the loss of RTKN-mediated protection against apoptosis but also greatly sensitized the cells to serum depletion-induced apoptosis. A trace amount of endogenous RTKN detected in the AGS/ Control cells was also diminished by the treatment of siRNA R (Figure 3a) . The ultrasensitivity to apoptotic insult was also observed in AGS/Control cells upon the treatment of siRNA R ( Figure 3b , panel 2), probably due to the depletion and inhibition of endogenous RTKN expression by siRNA R . On the contrary, the introduction of siRNA C had little effect on RTKN expression, nor did it affect the sensitivity of either AGS/Control or AGS/RTKN cells to apoptosis. The antiapoptotic function of RTKN was further substantiated by transfection of siRNA R into colorectal cancer H3347 cells that expressed endogenous RTKN at a high level followed by monitoring their ability to withstand apoptosis. Upon UV irradiation at 5 mJ/cm 2 , most of the H3347 cells remained viable and about 3-4% of cells were observed in sub-G1 fraction (Figure 3c ). After transfection of siRNA R to knockdown the expression of RTKN, the cells became more sensitive to UV-induced apoptosis that 38% of sub-G1 apoptotic population was observed, whereas transfection of cells with the control siRNA has little effect on the sensitivity toward UVinduced apoptosis (Figure 3c ). RTKN mediates Rho signaling to provide cell survival through activation of nuclear factor kB To study the signaling pathways that are involved in RTKN-mediated antiapoptosis, cells were incubated in serum-free medium in the presence of specific inhibitors of NF-kB, PI-3 kinase, or MAP kinase. As shown in Figure 4a , the NF-kB inhibitors, curcumin and parthenolide, caused only an insignificant change in the percentage of apoptotic AGS/Control cells, but produced a dramatic increase in the percentage of apoptotic AGS/RTKN cells, that reached the same level as in control cells. In contrast, the antiapoptotic effect of RTKN was not affected by the presence of the PI 3-kinase inhibitor, LY294002, or the MAP kinase , and subjected to serum starvation-induced apoptosis as described above. Immunoblotting was performed to determine RTKN expression in these cells using anti-Flag M2 inhibitor, PD98059. These data show that the prosurvival effect of RTKN is mediated through NF-kB activation and that the PI 3-kinase/Akt and MEK/ MAP kinase pathways are not involved. Reporter assays were next performed to examine the effect of RTKN on NF-kB activation in AGS cells. As shown in Figure 4b (left panel), RTKN and active RhoA.V14 were both strong inducers of NF-kB activation. Coexpression of RTKN and active RhoA.V14 caused stronger activation of NF-kB. Cotransfection and expression of C3 transferase, a specific inhibitor to the small GTPase Rho, greatly suppressed RTKN-induced NF-kB activation, suggesting that Rho activity is involved in RTKNinduced NF-kB activation. The RTKN-mediated NF-kB activation was also observed in cells of normal background. In fact, Rho/RTKN/NF-kB signaling pathway was observed in all cell lines examined, including the human GC AGS, NUGC-3, and SCM-1, colon cancer SW480, and H3347, lung cancer H1299, H322, and H358, Hs68 fibroblast and INT407 (embryonic intestine-derived epithelial) cells and mouse NIH-3T3 fibroblasts. The results of reporter assays performed in NIH3T3 cells were also shown ( Figure 4b , right panel). were transfected with RTKN siRNA (siRNA R ) or control siRNA (siRNA C ) as described in the 'Materials and methods'. After 24 h, cells were incubated in serum-free medium or treated with UV irradiation (5 mJ/cm 2 ) as indicated. After incubation for additional 48 h, cells were harvested for immunoblot and FACS analysis. Anti-Flag M2 antibody and polyclonal anti-RTKN antibodies were used to determine the expression of RTKN in these cells. The percentage of apoptotic cells was determined as described above NF-kB is present in its inactive form in the cytoplasm as a heterotrimeric complex of p50, p65, and the inhibitor, IkB. On activation, IkB is phosphorylated by IkBa kinases (IKKs), dissociates from the complex, and is degraded in the proteosome, while NF-kB is translocated to the nucleus, binds to DNA, and transactivates downstream target genes. An electrophoretic mobility shift assay (EMSA) was performed to determine whether NF-kB translocation was increased in RTKN-expressing cells. When nuclear extracts were prepared and tested for their ability to interact with the consensus NF-kB site, increased NF-kB DNA binding P]dCTP-labeled, double-stranded oligonucleotide containing the NF-kB binding site in the presence or absence of anti-p50 or anti-p65 antibodies. The protein-DNA interaction was analysed by electrophoresis on 5% polyacrylamide gel as described in the 'Materials and methods'. Shifted and supershifted complexes are indicated by an arrow and asterisks. In some experiments, an excess of unlabeled oligonucleotide (cold oligo) was added as competitor. (d) Phosphorylation of IkBa. AGS/RTKN and AGS/Control cells were incubated in serum-free medium for 48 h. After incubation in the presence and absence of TNF-a 10 ng/ml) for 6 h, 10 6 cells were collected and total cell lysates prepared for Western blot analysis against antiphospho-IkBa (e) RTKN-induced NF-kB activation is mediated through IkBa and IKKb. Reporter assays were performed by cotransfection of AGS cells with the pNFkB-Luc plasmid and either empty vector or expression vector encoding RTKN, with or without expression vectors encoding DN-IkBa, DN-IKKa, or DN-IKKb. Luciferase activity was measured and the fold induction was calculated as described above activity was seen in the nuclear extract from RTKNoverexpressing cells (Figure 4c ). The shifted band represented the specific interaction between NF-kB and its consensus DNA sequence, since antibodies specific for RelA (p65) or NF-kB1 (p50) super-shifted the band to a higher molecular mass. These results also suggested that the major NF-kB activity in AGS cells overexpressing RTKN consisted of p50 and p65 subunits. The specificity of NF-kB binding was further confirmed by a competition study using a 100-fold excess of unlabeled oligonucleotide (Figure 4c ). In line with this data, marked phosphorylation of IkBa was detected in AGS/RTKN cells but not in AGS/Control cells (Figure 4d ). The role of IkBa in Rho/RTKNmediated activation of NF-kB was further confirmed by cotransfection of AGS cells with RTKN and a supersuppressor IkBa mutant, IkBa(SS-AA), using the reporter assay. The supersuppressor IkBa(SS-AA) contains serine-to-alanine mutations at residues 32 and 36, which inhibit signal-induced phosphorylation and subsequent proteosome-mediated degradation of IkBa As shown in Figure 4e , RTKN-mediated activation of pNF-kB-Luc was completely blocked by the dominantnegative mutant IkBa(SS-AA), indicating that NF-kB activation by RTKN is mediated through IkBa phosphorylation. Given that IkBa phosphorylation is mediated by IKKa or IKKb, we investigated which IKK was responsible for NF-kB activation in RTKNexpressing cells by co-transfecting with the RTKN plasmid and plasmids encoding the dominant-negative forms of IKKa or IKKb and found that the dominantnegative IKKb mutant blocked NF-kB activation, while the dominant-negative IKKa mutant had little effect (Figure 4e) .
The most common mechanism of effector activation is by disruption of the intramolecular autoinhibitory interaction upon the binding of Rho GTPases, thus exposing the functional regulatory domain. A mutant effector protein containing only the GTPase-binding domain has been shown to act as a dominant-negative molecule by sequestering the respective GTPase, while removal of the GTPase-binding region is sufficient to render the effector active (Tu and Wigler, 1999; Watanabe et al., 1999; Kim et al., 2000) . We therefore tested the RTKN-N and RTKN-C mutant proteins for their ability to protect cells from apoptosis. As shown in Figure 5b , AGS cells stably expressing the RTKN-N mutant became supersensitive to serum depletioninduced apoptosis. On the other hand, the RTKN-C mutant conferred cells highly resistant to serum deprivation-induced apoptosis. Consistent with these observations, RTKN-C mutant strongly activated NFkB in the reporter assays and this activity was refractory to the inhibition by C3 transferase, suggesting its role as a dominant active mutant, whereas RTKN-N mutant was inactive to induce NF-kB activity and, furthermore, it worked as a dominant-negative mutant to block RhoA.V14-induced NF-kB activation (Figure 5c ). These results suggest that RTKN mediates Rho signaling to confer cells increased survival through the activation of NF-kB.
RTKN overexpression induces elevated expression of NF-kB antiapoptotic genes
NF-kB activation promotes cell survival by switching on the transcription of a series of antiapoptotic genes (Karin et al., 2002) . We further investigated whether RTKN overexpression induces the expression of antiapoptotic genes downstream of NF-kB in AGS cells and gastric adenocarcinomas. As shown in Figure 6a , after incubation in serum-free medium for 48 h, expression of the Bcl-xl, cIAP2, A1, and A20 transcripts was markedly increased in RTKN-expressing AGS cells, but not in cells containing the control vector, in which it remained at the same level as before serum deprivation. The relative expression of the transcripts of these NF-kB target genes determined by real-time PCR analysis is also shown (Figure 6b ). As shown in Figure 6c (upper panel), overexpression of RTKN was seen in five of seven (71%) primary GCs where RTKN was increased in expression by 1.6 to 4.4-fold as compared to the nontumorous mucosa. A marked increase in transcrip- Reporter assays were performed in AGS cells by transfection with a pNF-kB-Luc plasmid and expression vector encoding RTKN-N, or RTKN-C along with or without the vector encoding RhoA.V14 or C3 transferase as indicated. Luciferase activity was measured and the fold induction was calculated as described above tion of NF-kB antiapoptotic genes cIAP2, A1, A20, and Bcl-xL was observed in the RTKN-overexpressing primary gastric adenocarcinoma tissues (Figure 6c , lower panel). Although NF-kB drives mammary epithelial cell proliferation during pregnancy by turning on expression of cyclin D1 (Cao et al., 2001) , in our study, cyclin D1 expression in GC cells was not affected by RTKN expression.
RTKN overexpression is associated with increased chemoresistance
Resistance to apoptosis represents one of the major mechanisms whereby tumors are able to resist chemoand radiotherapy. Elevated NF-kB activity is reported to be associated with chemoresistance in pancreatic cancer cell lines, and blockade of this activity significantly increases the chemosensitivity of the cells (Arlt et al., 2002) . We therefore tested the chemosensitivity of RTKN-expressing AGS cells in the WST-1 viability assay by incubating the control and RTKN-expressing AGS cells with increasing concentrations (1-100 mg/ml) of fluorouracil (5-FU), one of the most effective clinical antitumor agents available for the treatment of gastrointestinal cancer. As shown in Figure 7 (upper trace), the cytotoxic effect of 5-FU on control cells was dosedependent, cell viability being reduced to 20% after 72 h treatment with 100 mg/ml 5-FU, whereas, under the same conditions, more than 70% of RTKN-expressing cells remained viable. To verify that the increased chemoresistance of the RTKN-expressing AGS cells was dependent on NF-kB activity, we tested the effect Figure 6 RTKN overexpression stimulates the expression of NF-kB downstream antiapoptotic genes. (a) Expression of NF-kB antiapoptotic genes in AGS cells. Total RNA was prepared from AGS/RTKN and AGS/Control cells that were cultured in serum-free medium for the indicated time, and the levels of cIAP2, Bcl-xL, A1, A20, and cyclin D1 transcripts were determined by RT-PCR analyses. GAPDH expression was used as a control to monitor RNA quality and concentration. (b) Real-time PCR analysis of relative expression of NF-kB antiapoptotic genes in AGS cells. (c) RTKN expression and differential expression of NF-kB antiapoptotic genes in primary GC. Total RNA was prepared from tumor (T) and matched nontumor (N) tissue from GC patients (ID numbers given above panel), and subjected to RT-PCR analyses. Top panel shows PCR products amplified using primers specific for RTKN and GAPDH, respectively. Relative RTKN values were determined by densitometric analyses of RTKN-specifc products after normalization to that of GAPDH. GC that showed elevated expression of RTKN transcripts were subjected to real-time PCR analyses of the expression of NF-kB antiapoptotic genes of an NF-kB inhibitor, curcumin, and found that it increased the chemosensitivity of RTKN-expressing cells to a similar level to that of control AGS cells (Figure 7 , upper trace), showing that the cytoprotective effect of RTKN was mediated mainly through NF-kB activation. Similar results were obtained using another chemotherapeutic agent, paclitaxol (1 nM-10 mM) (Figure 7 , lower trace), where less than 30% of control AGS cells remained viable after treatment with 1 nM paclitaxol for 72 h. In contrast, more than 80% of the RTKN-expressing cells remained viable even when treated with much higher concentrations of paclitaxol (10-10 000 nM). As expected, the cytoprotective effect of RTKN was also significantly compromised if the cells were incubated with curcumin. The vector-containing control clones were as sensitive to the cytotoxic effect of 5-FU and paclitaxol as the parental AGS cells, indicating that transfection and selection did not affect the sensitivity of cells to these agents (data not shown). These results show that constitutive expression of RTKN in AGS cells renders them significantly more resistant to cytotoxic agents and the resistance can be attenuated by the incorporation of an NF-kB inhibitor.
Discussion
Our data support an important role of Rho/RTKNmediated signaling pathway in the pathogenic development of human GC. We demonstrated that RTKN mediates Rho signaling to activate NF-kB, with concomitant enhanced expression of NF-kB downstream antiapoptotic genes. These data suggest that activation of Rho/RTKN/NF-kB signaling pathway through RTKN overexpression renders cells resistant to apoptotic insults and enables them to evade apoptosis during the process of transformation, and may therefore represent an important molecular event in gastric tumorigenesis. In line with the high potential of RTKN leading to the transactivation of NF-kB antiapoptotic genes, GC cells overexpressing RTKN displayed increased resistance to antitumor drugs, further suggesting that signaling pathways eliciting NF-kB activation may be important targets for novel therapeutic approaches in the treatment of human GC.
The Rho/RTKN-mediated cell survival was shown to be NF-kB-dependent, because treatment with curcumin or parthenolide completely abolished the increased resistance to apoptotic insults (Figure 4a ). Although Rho GTPase promotes cell survival, partly via activation of PI-3 kinase and subsequent activation of Akt/ PKB (Maeda et al., 2000) , our data clearly showed that PI-3K/Akt pathway is not involved in Rho/RTKNmediated cell survival. In addition, the Ras/MAP kinase pathway, which has been shown to block cell death in other systems, was not involved in RTKN-mediated antiapoptosis. Elevated NF-kB activity has been found in a number of malignant tumors (Arlt et al., 2002; Bhat-Nakshatri et al., 2002; Chiao et al., 2002) . Permanent amplification of NF-kB activity may involve mutations and/or over-representation of members of the Rel protein family (Romero and Humphries, 1995) Sanlioglu et al., 2001) . In certain breast and pancreatic tumors and cell lines, the autocrine action of IL-1 and IL-1b has been described to induce NF-kB-dependent protection from apoptosis (Nakshatri et al., 1997; Arlt et al., 2002; Bhat-Nakshatri et al., 2002) . Complementary to these findings, our data have clearly demonstrated that, in a subset of GCs, NFkB activity was elevated as a result of activated Rho signaling pathway through overexpressed effector protein RTKN. The Rho GTPases, Rho, Rac, and Cdc42, are also activated by the upstream GEF Dbl to induce NF-kB activity; whereas Rac stimulates the activity of IKKb, Cdc42 and Rho activate NF-kB by IKKindependent pathways (Cammarano and Minden, 2001) . In this study, we found that RTKN-mediated Rho signaling pathway leading to enhanced nuclear NF-kB activity involves activation of IKK-b, which phosphorylates, and thereby induces proteasomal degradation of, IkBa (Figure 4c-e) . In addition, our data further suggested that the Rho/RTKN/NF-kB signaling pathway appears to be present in many cell types. Using reporter assays, RTKN-mediated NF-kB activation was examined in 11 representative cell lines that expressed Rho/RTKN/NF-jB axis and antiapoptosis C-A Liu et al endogenous RTKN at different levels. These cell lines included human GC AGS, NUGC-3, and SCM-1, colon cancer SW480 and H3347, lung cancer H1299, H322, and H358, Hs68 fibroblast and INT407 (embryonic intestine-derived epithelial) cells and mouse NIH-3T3 fibroblasts. Our data showed that RTKN induced NFkB activation in all cell lines tested (the data from AGS and NIH3T3 were shown in Figure 4b ). Interestingly, an inverse correlation of RTKN-induced NF-kB activation and endogenous RTKN expression level was observed that NF-kB activation was markedly induced in cell lines that expressed endogenous RTKN at undetectable or low level, whereas less strong induction was observed in cell lines that expressed endogenous RTKN at high level (Supplementary Figure 1) . It may reflect that RTKN-expressing cell lines exert high background of endogenous NF-kB activity and therefore limited fold of induction was achieved upon expression of ectopically introduced RTKN. These data suggest that RTKN mediates Rho signaling pathway leading to NF-kB activation, and that dysregulation of this pathway through overexpression of the effector protein RTKN may represent a common mechanism in the tumorigenic process. RTKN was initially isolated as a target molecule for the small GTPase, Rho (Reid et al., 1996) . It contains the Rho binding domain in its amino terminus, a PH domain in the central region, two PXXP motifs, and the carboxy terminal QSPV-COOH sequence, which recognizes PSD-95/Discs-large/ZO-1 (PDZ) domain. Its Rho binding domain shows 30% amino-acid sequence identity with those of two other Rho target proteins, the serine/threonine kinase, PKN, and rhophilin. This class of Rho-binding domain, termed the Rho effector motif class I (REM-1), shows no similarity to the binding motifs of the Rac/Cdc42 effectors, nor is it present in the coil-bearing Rho effectors, such as ROCK and citron (Reid et al., 1996) . Acting as a scaffold protein, RTKN was recently shown to interact with TIP-1 and greatly enhanced the Rho-mediated activation of serum response element (Reynaud et al., 2000) . Other possible links downstream of RTKN that elicit Rho-mediated signal transduction remain largely unexplored. In this study, we demonstrated that RTKN links Rho activity to induce NF-kB activity. Our data showed that the inhibition of Rho activity by coexpression of C3 transferase significantly suppresses RTKNmediated NF-kB activation (Figure 4b ), suggesting that RTKN works downstream to mediate Rho activity. This was further substantiated by the findings that RTKN-N mutant protein, which contains the Rho binding domain, acts as a dominant-negative molecule to block RhoA.V14-induced NF-kB activity, whereas the RTKN-C mutant protein acts as a dominant-active molecule to induce robust NF-kB activity that is independent of Rho activity (Figure 5c ). Consistent with these findings, expression of RTKN-C mutant renders cells highly resistant to serum deprivationinduced apoptosis and cells expressing RTKN-N mutant became supersensitive to apoptosis (Figure 5b) . It is noted that coexpression of C3 transferase inhibits Rho activity but does not completely abolish RTKNinduced NF-kB activation (Figure 4b ). In agreement with these data, we also found that RTKN-mediated antiapoptotic effect was greatly but not completely inhibited by C3 transferase (Supplementary Figure 2) . Several possibilities exist for the observed phenomena. Firstly, overexpression of RTKN may facilitate an intermolecular interaction between RTKN molecules that relieves an intramolecular contact between the GTPase binding domain and autoinhibitory domain. Alternatively, RTKN may work as an effector for proteins other than Rho. Further studies are required to test these hypotheses. Nevertheless, our data suggest that RTKN mediates Rho activity leading to increased cell survival through the activation of NF-kB and subsequent induction of its downstream antiapoptotic genes. NF-kB is also known to induce the expression of gene products that control proliferative responses (Karin et al., 2002) . However, in the context of this study, AGS cells expressing RTKN at a high level did not gain significant growth advantage over the parental or vector-transfected control cells (data not shown). In agreement with these observations, the expression of cyclin D1 transcripts remained unchanged in GC cells that overexpressed RTKN (Figure 6 ).
In view of that NF-kB activation suppresses apoptosis by inducing the expression of certain antiapoptotic genes, NF-kB activity may play a detrimental role in blocking the efficacy of cancer chemotherapies and radiation. Given that sustained NF-kB activation has been reported in a number of cancers, these tumors may have developed a level of chemoresistance prior to cancer therapy. In line with this notion, Chuang et al. (2002) have recently reported that the basal level of NF-kB activity in a series of representative cancer cell lines was heterogeneous and was inversely correlated with the sensitivity of these cell lines to several major anticancer drugs. In this study, we showed that Rho/ RTKN-mediated NF-kB activation in GC cells was associated with increased chemoresistance and blockade of NF-kB activity strongly attenuated the increased resistance (Figure 7 ). These data demonstrated that the apoptotic response to genotoxic anticancer drugs is greatly desensitized in tumor cells where NF-kB is constitutively active, and inhibition of NF-kB activity in these cells may therefore tremendously enhance their sensitivity to such treatment.
In conclusion, we have established in this study that Rho/RTKN/NF-kB signal axis confers cell resistance to apoptosis. We demonstrated that RTKN overexpression leads to sustained NF-kB activity, with concomitant induction of the expression of NF-kB antiapoptotic genes. These data suggest that overactivated Rho/RTKN/NF-kB signaling pathway may play an important role in gastric tumorigenesis. In addition, GCs with an overactivated Rho/RTKN/NF-kB signaling pathway displayed higher resistance to antitumor drugs and the resistance was significantly attenuated by the incorporation of NF-kB inhibitor, suggesting that combining NF-kB blockers with other chemotherapeutic agents may be of great benefit in the treatment of a subset of GC patients.
Materials and methods
Plasmids and materials
The plasmid pFLAG-CMV2-RTKN encoding the full-length RTKN was constructed as described (Liu et al., 2004) . pFlag-CMV-RTKN-N and pFlag-CMV-RTKN-C were constructed by PCR amplification of the corresponding DNA fragments encoding the N-terminal region containing the Rho-binding domain (amino acids 1-188) and the C-terminal region (amino acids 295-551) of human RTKN, respectively, using the pFLAG-CMV2-RTKN as template, and subsequent subcloning of the PCR products into pFLAG-CMV2 vector. The sequences of the plasmids were verified using an ABI Prismt 370 autosequencer (Applied Biosystems, Foster City, CA, USA). The vectors encoding constitutively activated RhoA.V14 in pUHD and C3 transferase in pEF1a have been previously described (Lai et al., 2001) . pCMV4-IkBa(S32A/S36A), encoding a dominant-negative IkBa (DN-IkBa), was provided by Dr DW Ballard (Scherer et al., 1995) . pcDNA3-IKKa (D144N), encoding DN-IKKa and pcDNA3-IKKb(K44A), encoding DN-IKKb were gifts from Dr CV Paya (Asin et al., 1999) . PD098059, curcumin, parthenolide, LY294002, and anti-Flag M2 antibody were purchased from Sigma Chemical Co. (St Louis, MO, USA).
Mammalian cell transfection and NF-kB reporter assays
The human gastric adenocarcinoma AGS, colorectal adenocarcinoma H3347, and the non-small-cell lung cancer H1299 cell lines, and mouse NIH3T3 cell line were purchased from American Type Culture Collection. AGS cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum and 100 mg/ml of penicillin/ streptomycin/gentamycin at 371C in a humidified atmosphere of 5% CO 2 . NIH3T3 cells were maintained in DMEM supplemented with 10% calf serum, and H3347 and H1299 cells were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum and 100 mg/ml of penicillin/ streptomycin/gentamycin under the same condition. At 24 h before transfection, the cells were transferred to serum-free medium. Transient transfection was performed with 1 mg of NF-kB luciferase plasmid (pNF-kB-Luc, Strategene USA, La Jolla, CA, USA) and 300 ng of pFlag-CMV2, pFlag-CMV-RTKN, pFlag-CMV-RTKN-N, or pFlag-CMV-RTKN-C using the LipofectAMINE-2000 method (Invitrogen Corp., Carlsbad, CA, USA), according to the manufacturer's protocol. A CMV-driven b-galactosidase expression vector was also cotransfected to monitor transfection efficiency. Cells were harvested 30 h after transfection under serum-free conditions, and cell lysates were prepared and luciferase activities were measured. Luciferase activity was normalized to the bgalactosidase activity. In some experiments, a plasmid encoding RhoA.V14 or C3 transferase was also cotransfected. All experiments were performed in duplicate and at least three times.
To generate AGS or H1299 cells stably expressing RTKN and its mutants, cells were cotransfected with pFlag-CMV2-RTKN, pFlag-CMV2-RTKN-N, or pFlag-CMV2-RTKN-C plasmid along with pcDNA3 vector (neo r ) at 10 : 1 ratio using the electroporation method as described previously (Chen et al., 1993) . At 16 h post-transfection, cells were transferred to fresh medium containing neomycin at a final concentration of 500 mg/ml. After 14 days, G418-resistant clones were established. AGS cells stably harboring the empty pFlag-CMV2 plasmid DNA were also established by the same selection procedure and were used as controls.
Expression of RTKN was detected by Western blot analysis. Cells were lysed in 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 0.5% Triton X-100, 0.5% sodium deoxycholate, 10 mM Na 4 P 2 O 7 , 50mM sodium fluoride, 20 mg/ml of leupeptin, 20 mg/ml of aprotinin, and 1 mM phenylmethylsulfonyl fluoride, and the protein concentration was determined using a commercial kit based on the Bradford method (Bio-Rad Laboratories, Richmond, CA, USA). Equal amounts of protein were fractionated by SDS polyacrylamide gel electrophoresis and transferred onto a polyvinylidenedifluoride membrane, which was then incubated with anti-Flag M2 antibody and polyclonal antibodies specifically recognizing RTKN, respectively, followed by peroxidase-conjugated secondary antibodies. Proteins were detected using the enhanced chemiluminescence system (Amersham Pharmacia Biotech., Buckinghamshire, England). Polyclonal antibodies against RTKN were generated by immunizing rabbit with a synthetic peptide corresponding to RTKN sequence from amino acids 43-57 (RKLDHEIRMREGACK). Antibody against phosphor-IkB-a was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Flow cytometric analysis
Cells were seeded at 1 Â 10 5 cells/well in six-well microplates and incubated overnight in medium containing 10% fetal calf serum. To induce apoptosis, cells were cultured in serum-free RPMI-1640 medium and incubated for the indicated times, the cells were harvested, treated with RNaseA, incubated with 50 mg/ml of propidium iodide for 30 min at room temperature, then analysed immediately by flow cytometry (FACSCalibur, Becton Dickinson, USA).
RNA interference
Annealed, purified, and desalted double-stranded RTKN siRNA (sense, 5 0 -AGC AUC AGU AAC CAG UAU GTT-3 0 ; and antisense, 5 0 -CAU ACU GGU UAC UGA UGC UTT-3 0 ) were ordered from Qiagen. A pair of RNA oligonucleotides that do not share sequence homology to any mammalian genes was also purchased from Qiagen to serve as control siRNA (Xia et al., 2002) . The day before transfection, 2 Â 10 5 cells were seeded in 60-mm plate. Cells were transfected with 1 mM RTKN siRNA or control siRNA in 100 ml EC-R buffer (Qiagen) using LipofectAMINE 2000 (Invitrogen), according to the protocol recommended by Qiagen. After 6 h, the cells were changed into medium containing 10% FBS. To induce apoptosis, cells were incubated in serum-free medium instead of the serum-containing medium. After incubation for an additional 48 h, cells were harvested for the assessment of RTKN expression and apoptosis.
Electrophoretic mobility shift assay
Nuclear extracts were prepared as described previously (Schreiber et al., 1993) . Briefly, 6 Â 10 6 cells were collected by centrifugation at 110 g for 5 min, washed with ice-cold phosphate-buffered saline (PBS), suspended in 200 ml of buffer containing 10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, and 1 Â protease inhibitor (final concentrations 1 mM ABESF-HCl, 150 nM aprotinin, 15 mM E-64, and 20 mM leupeptin), and incubated on ice for 15 min. After addition of 12.5 ml of 10% Nonidet P-40, the sample was mixed thoroughly for 10 s using a Vortex mixer, then centrifuged at 10 000 g at 41C for 3 min. The nuclear pellets thus obtained were resuspended in 25 ml of icecold extraction buffer (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol and 1 Â protease inhibitor) and kept on ice for 15 min with intermittent agitation. After centrifugation at 10 000 g for 5 min at 41C, the supernatants were collected as nuclear protein extracts. A double-stranded oligonucleotide containing the NF-kB consensus binding site, prepared by annealing two synthetic oligonucleotides (5 0 -CGC GAG TTG AGG GGA CTT TCC CAG GC-3 0 and 5 0 -CGC GGC CTG GGA AAG TCC CCT CAA CT-3 0 ; NF-kB binding site underlined), was radiolabeled with Klenow enzyme in the presence of [a- 32 P]dCTP. Binding was performed by incubating nuclear extracts (10 mg) for 30 min at room temperature with the radiolabeled probe (1 Â 10 6 cpm) in 15 ml of buffer containing 10 mM HEPES, pH 7.6, 200 ng/ml poly(dI-dC), 0.1% NP-40, 10% glycerol, 1 mM DTT, 5 mM MgCl 2 , and 50 mM NaCl in the presence or absence of antibodies against p50 or p65 (0.2 mg) (CHEMI-CON International Inc., Temecula, CA, USA). The protein-DNA interaction was analysed by electrophoresis on a nondenaturing 5% polyacrylamide gel, followed by autoradiography.
RNA isolation, RT-PCR and real-time PCR
Gastric adenocarcinoma tissue and matching nontumor mucosal tissue were obtained from patients who underwent surgery at the Veterans General Hospital-Taipei. Informed consent was obtained from each patient. They consisted of biopsies from five males and two females, representative of two intestinal, one diffuse, and four mixed type GC. Tissues were snap-frozen immediately following resection. Total RNA was prepared from homogenized tissues using the guanidine isothiocyanate method and pelleted through a 5.7 M CsCl cushion. Total RNA was prepared from cell lines using the TRIZOL reagent (Invitrogen Corp., Carlsbad, CA, USA).
In total, 5 mg of total RNA was converted to cDNA using 200 U of MMLV reverse transcriptase (SuperscriptII, Invitrogen Corp., Carlsbad, CA, USA) in 50 ml of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, and 1 mM dNTP containing 0.625 mg of random primers, following the manufacturer's instructions. The polymerase chain reaction (PCR) was carried out in a 10 ml reaction mixture containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 3 mM MgCl 2 , 0.01% (w/ v) gelatin, 2 mM dNTP, 0.1 mg/ml of each primer, 1 ml of suitably diluted cDNA, and 2.5 U of Taq DNA polymerase. In total, 30 cycles of PCR (941C for 30 s, 651C for 30 s, and 721C for 1 min) were performed using the following primers: RTKN transcripts (sense primer, 5 0 -GAG CGC ACT GAG CAG GCA AAG-3 0 ; antisense primer, 5 0 -CAG GAT CCA TAC AGC TCT AAC CGC AGT TC-3 0 ; GenBank Accession # BC004558), A1 transcripts (sense primer, 5 0 -CAA GAC TTT GCT CTC CAC CA-3 0 ; antisense primer, 5 0 -GGC AAT CGT TTC CAT ATC AGT-3 0 , GenBank Accession # NM_004049), A20 transcripts (sense primer, 5 0 -GAG AGC ACA ATG GCT GAA CA-3 0 ; antisense primer, 5 0 -CCA GTG TGT ATC GGT GCA T-3 0 ; GenBank Accession # NM_006290), BCL-xl transcripts (sense primer 5 0 -ACC CAT CCT GGC ACC TGG CA-3 0 , and antisense primer 5 0 -GGA TCC AAG GCT CTA GGT GG-3 0 ; GenBank Accession # NM_138578), cIAP2 transcripts (sense primer, 5 0 -CAA CCC CAA AGA GTT GTG TTC-3 0 ; antisense primer, 5 0 -GAG GCA GTT TTG TGC ATG AG-3 0 ; GenBank Accession # NM_001165), cyclin D1 transcripts (sense primer, 5 0 -GCT GCG AAG TGG AAA CCA TC-3 0 ; antisense primer 5 0 -CAG GAC CTC CTT CTG CAC AC-3 0 ; GenBank Accession #NM_053056). In total, 25 cycles of PCR (941C for 30 s, 551C for 30 s, and 721C for 1 min) were performed using primers specific for GAPDH transcripts (sense primer, 5 0 -TGG TAT CGT GGA AGG ACT CAT GAC-3 0 ; antisense primer, 5 0 -ATG CCA GTG AGC TTC CCG TTC AGC-3 0 ; GenBank Accession # NM_002046). PCR products were separated by agarose gel electrophoresis and examined under UV after ethidium bromide staining.
Quantitative real-time PCR was carried out using the DNA Engine Opticon s 2 System (MJ Research Inc., Reno, Nevada, USA) in a final volume of 20 ml with 1 Â FastStart DNA Master SYBR Green I mix (Roche Diagnostics GmBH, Germany) with 2 mM of primers, 2 ml of relevant sample cDNA, and magnesium chloride adjusted to a final concentration of 1.5 mM. Primers used and cycling conditions were described as above. The GAPDH primer set was used as the reference control for normalization. The threshold cycles (C T ) were recorded for all samples for both the target gene and GAPDH. Melt curve analysis was performed for each run. Relative gene expression of the target gene was calculated as DC T , determined by subtracting the C T of reference gene from the C T of target gene. Differential expression of the target gene in tumor vs nontumor mucosal samples was shown as DDC T , determined by subtracting the DC T of tumor sample from the DC T of the matching mucosal sample.
Cell viability assay
The WST tetrazolium assay was used to measure the cell viability (Mosmann, 1983) . Briefly, approximately 5 Â 10 4 target cells/well were plated in triplicate in 96-well microtiter plates and incubated for the indicated time at 371C in the presence or absence of the indicated test samples in a final volume of 0.1 ml. In total, 10 ml of the cell proliferation reagent, WST-1, (Roche Molecular Biochemicals, Mannheim, Germany) was added and incubation continued for 4 h. The formazan dye formed was quantified by scanning the plates on a microplate reader at a wavelength of 440 nm. Relative cell viability was calculated by comparing the OD of the test samples to that of the medium control.
Abbreviations GC, gastric cancer; NF-kB, nuclear factor-kB; IkB, inhibitory subunit of NF-kB; IKK, IkBa kinase; MAPK, mitogenactivated protein kinase; PI 3-kinase, phosphatidylinositol 3-kinase; RT-PCR, reverse transcription-polymerase chain reaction; FACS, fluorescence-activated cell sorting.
